COVID-Era Acquisitions Favored Shareholders While Stakeholder Protections Went Missing
The COVID period became a public test case for stakeholder capitalism, with corporate leaders publicly invoking duties to employees, customers, suppliers, communities, and the environment. The acquisition market told a different story. Across the $1 billion-plus public-company deals announced from April 2020 through March 2022, negotiating teams secured large gains for target shareholders and substantial private benefits for corporate leaders, while leaving stakeholder protections largely on the table.
The analysis covered 122 acquisitions with an aggregate consideration exceeding $800 billion. Within that set, 24 acquisitions above $10 billion received full case-level treatment in the main article, while this appendix extends the same kind of detailed review to the 98 acquisitions valued between $1 billion and $10 billion. The result is a broader picture of how dealmakers behaved when pandemic-era uncertainty should have made labor continuity, supply resilience, and community continuity especially salient.
One sentence captures the central divergence: employee protections were usually absent.
Deal Terms Rewarded Owners, Not the Stakeholders Most Exposed to Post-Deal Risk
The pattern is straightforward. Target shareholders received substantial value, but corporate leaders rarely negotiated for provisions that would cushion employees facing layoffs after closing. Even in transactions widely understood at the time to carry serious post-deal risks for the workforce, protections such as payments to laid-off employees were uncommon. The same gap extended beyond labor. Protections for customers, suppliers, communities, the environment, and other stakeholders were also largely absent from the negotiated terms.
This is not a trivial omission in corporate deal design. A transaction can transfer ownership efficiently while still imposing sharp external costs on groups that do not sit at the bargaining table. Employees can lose jobs, local communities can absorb economic shocks, and suppliers can face abrupt revenue loss. If stakeholder capitalism were functioning as advertised, pandemic-era uncertainty would have been a moment when those interests were translated into binding provisions. Instead, the contract terms suggest a different incentive structure at work.
The appendix emphasizes that these findings do not come from a narrow slice of exceptional deals. They supplement the article’s broader report on the full sample of 112 acquisitions and offer case-level detail across the $1 billion to $10 billion segment. That matters because the pattern appears across a wide swath of transactions rather than in one or two conspicuous outliers. The consistency makes the absence of stakeholder protections harder to dismiss as random noise.
Incentives Pointed Toward Shareholder Value, Not Broader Corporate Commitments
The article does not leave the result as a simple descriptive observation. It tests whether other explanations could account for the observed pattern and concludes that the most plausible driver is corporate leaders’ incentives not to benefit stakeholders beyond what would serve shareholder interests. In practical terms, the dealmaking environment rewarded arrangements that maximized what owners received while giving less weight to parties whose welfare was exposed but not directly priced into the transaction.
That conclusion aligns with the agency critique of stakeholder capitalism. When executives and dealmakers control the negotiation, they may speak in the language of broad duty while still optimizing for the interests that are easiest to measure, defend, and monetize. Shareholders benefit directly from a higher price. Executives can also obtain private benefits. Employees, by contrast, often need explicit contractual protection to avoid being treated as a residual concern once value transfer has been locked in.
The paper also pushes back on the implicit-promises or team-production view. Under that framework, corporate leaders are expected to protect stakeholder interests because doing so supports the trust, cooperation, and investment that ultimately serve shareholders. The acquisition record described here does not fit that model well. Pandemic risk should have made the operational value of those relationships more visible, not less. Yet deal terms still failed to reflect a robust commitment to stakeholders.
The Appendix Strengthens the Case by Expanding the Deal-by-Deal Record
This appendix matters because it broadens the evidentiary base beyond the largest transactions. The main article already examined the 24 acquisitions above $10 billion in detail. The appendix extends the analysis to the 98 acquisitions in the $1 billion to $10 billion range, creating a more complete picture of how COVID-era acquisition negotiations handled stakeholder concerns. The dataset includes 122 acquisitions in total and more than $800 billion in aggregate consideration, a scale large enough to make the pattern difficult to ignore.
The deals were announced during a period when corporate leaders repeatedly expressed support for stakeholderism. That rhetorical backdrop raised expectations that pandemic-era transactions would reflect heightened concern for employees and other nonshareholder constituencies. Instead, the bargain structure repeatedly privileged the interests of owners. The contrast between public commitments and contract language is the sharpest feature of the study.
A second sentence captures the bedside-like operational consequence of this corporate behavior: the risk of job loss was rarely paired with compensation.
What the Findings Mean for Corporate Governance and Ongoing-Concern Decisions
Although the study centers on acquisitions, the implications reach beyond change-of-control events. Decisions about ongoing business operations also involve tradeoffs among owners, workers, customers, and communities. If leaders do not reliably negotiate for stakeholder protections when transactions create visible risk, their willingness to do so in routine governance decisions becomes even more doubtful. The paper uses that logic to widen the relevance of the findings without overstating them.
The evidence also speaks to a broader governance debate that has intensified during and after the pandemic. Stakeholder capitalism gained traction in speeches, policy statements, and corporate branding, but the actual allocation of deal protections offers a more concrete test than rhetoric alone. In that setting, the paper’s conclusion is stark: corporate leaders cannot be assumed to protect stakeholders when doing so does not clearly advance shareholder value.
For health systems, employers, and community-facing institutions, the lesson is indirect but important. Large organizational transactions can carry real human consequences even when they are framed as financial optimizations. Employment continuity, supplier stability, and community impact are not abstract public-relations themes; they are the mechanisms through which corporate decisions affect daily life. When negotiation omits those protections, the burden shifts outward to groups least able to absorb it.
The appendix closes the evidentiary gap for mid-sized pandemic-era acquisitions, but it leaves the core policy question unresolved: whether stakeholder protection can be made durable through rhetoric alone, or whether it requires enforceable constraints in transaction design and corporate governance.